Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preetesh Jain

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Cancer Research Communications|August 4, 2023
Integrative Prognostic Machine Learning Models in Mantle Cell LymphomaHolly A Hill, Preetesh Jain, Chi Young Ok, et al.
American Journal of Hematology|April 9, 2015
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemiaPreetesh Jain, Shimin Hu, Elias Jabbour, et al.
American Journal of Hematology|January 23, 2016
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutationPreetesh Jain, Guilin Tang, Yang O Huh, et al.
American Journal of Hematology|March 27, 2015
Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndromePreetesh Jain, Srdan Verstovsek, Sanam Loghavi, et al.
Leukemia & Lymphoma|October 1, 2019
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)Mansour Alfayez, Beenu Thakral, Preetesh Jain, et al.
Leukemia & Lymphoma|December 25, 2015
DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemiaPreetesh Jain, Srdan Verstovsek, Wei Wang, et al.
American Journal of Hematology|October 7, 2015
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutationsPreetesh Jain, Guilin Tang, Sergej N Konoplev, et al.
Blood|March 1, 2014
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemiaYoung Kwang Chae, Long Trinh, Preetesh Jain, et al.
American Journal of Hematology|May 12, 2020
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myelomaElisabet E Manasanch, Preetesh Jain, Wendy Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity?Preetesh Jain, Chi Young Ok, Sergej Konoplev, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Cancer Research Communications|August 4, 2023
Integrative Prognostic Machine Learning Models in Mantle Cell LymphomaHolly A Hill, Preetesh Jain, Chi Young Ok, et al.
American Journal of Hematology|April 9, 2015
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemiaPreetesh Jain, Shimin Hu, Elias Jabbour, et al.
American Journal of Hematology|January 23, 2016
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutationPreetesh Jain, Guilin Tang, Yang O Huh, et al.
American Journal of Hematology|March 27, 2015
Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndromePreetesh Jain, Srdan Verstovsek, Sanam Loghavi, et al.
Leukemia & Lymphoma|October 1, 2019
First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)Mansour Alfayez, Beenu Thakral, Preetesh Jain, et al.
Leukemia & Lymphoma|December 25, 2015
DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemiaPreetesh Jain, Srdan Verstovsek, Wei Wang, et al.
American Journal of Hematology|October 7, 2015
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutationsPreetesh Jain, Guilin Tang, Sergej N Konoplev, et al.
Blood|March 1, 2014
Statin and aspirin use is associated with improved outcome of FCR therapy in relapsed/refractory chronic lymphocytic leukemiaYoung Kwang Chae, Long Trinh, Preetesh Jain, et al.
American Journal of Hematology|May 12, 2020
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myelomaElisabet E Manasanch, Preetesh Jain, Wendy Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Relapsed Refractory BRAF-Negative, IGHV4-34-Positive Variant of Hairy Cell Leukemia: A Distinct Entity?Preetesh Jain, Chi Young Ok, Sergej Konoplev, et al.
Pageof 18